1,3,4-oxadiazole has been researched along with Inflammation in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YL; Duan, YJ; Li, QS; Liu, ZG; Meng, HW; Meng, XS; Shen, ZB; Wang, TX; Wang, XR; Yang, XX; Yin, ZQ; Zhang, S; Zou, TF | 1 |
| Ali Shah, F; Khan, AU; Li, S; Mohsin Alvi, A; Nadeem, H; Sadiq Sheikh, A; Tariq Al Kury, L; Tariq Khan, M; Umar Ijaz, M; Zeb, A | 1 |
| Bader, M; Celik, T; Dedeoglu-Erdogan, A; Gurdal, EE; Koksal, M; Ozgurbuz, M; Reis, R; Sipahi, H; Sippl, W | 1 |
| Baev, DS; Frolova, TS; Popov, SA; Semenova, MD; Shults, EE; Sorokina, IV; Tolstikova, TG; Turks, M; Zhukova, NA | 1 |
| Chawla, G; Naaz, B; Siddiqui, AA | 1 |
1 review(s) available for 1,3,4-oxadiazole and Inflammation
| Article | Year |
|---|---|
Exploring 1,3,4-Oxadiazole Scaffold for Anti-inflammatory and Analgesic Activities: A Review of Literature From 2005-2016.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Humans; Inflammation; Molecular Structure; Oxadiazoles | 2018 |
4 other study(ies) available for 1,3,4-oxadiazole and Inflammation
| Article | Year |
|---|---|
Novel flavonoid 1,3,4-oxadiazole derivatives ameliorate MPTP-induced Parkinson's disease via Nrf2/NF-κB signaling pathway.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Inflammatory Agents; Antioxidants; Disease Models, Animal; Flavonoids; Inflammation; Mice; Mice, Inbred C57BL; Neuroprotective Agents; NF-E2-Related Factor 2; NF-kappa B; Parkinson Disease; Signal Transduction | 2023 |
Post-Treatment of Synthetic Polyphenolic 1,3,4 Oxadiazole Compound A3, Attenuated Ischemic Stroke-Induced Neuroinflammation and Neurodegeneration.
Topics: Animals; Antioxidants; Brain Ischemia; Inflammation; Ischemic Stroke; Male; Molecular Structure; Neuroprotective Agents; Oxadiazoles; Oxidative Stress; Rats; Rats, Sprague-Dawley | 2020 |
Design, synthesis, and molecular docking of novel 3,5-disubstituted-1,3,4-oxadiazole derivatives as iNOS inhibitors.
Topics: Animals; Anti-Inflammatory Agents; Carrageenan; Disease Models, Animal; Edema; Enzyme Inhibitors; Indomethacin; Inflammation; Macrophages; Male; Mice; Mice, Inbred BALB C; Molecular Docking Simulation; Nitric Oxide Synthase Type II; Oxadiazoles; RAW 264.7 Cells; Structure-Activity Relationship | 2021 |
Lupane-type conjugates with aminoacids, 1,3,4- oxadiazole and 1,2,5-oxadiazole-2-oxide derivatives: Synthesis, anti-inflammatory activity and in silico evaluation of target affinity.
Topics: Amino Acids; Animals; Anti-Inflammatory Agents; Computer Simulation; Concanavalin A; Disease Models, Animal; Edema; Female; Fibroblasts; Histamine; Inflammation; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Molecular Conformation; Molecular Docking Simulation; NF-E2-Related Factor 2; NF-kappa B; Oxadiazoles; Triterpenes | 2019 |